Search Results for "Mgus Latest News"

17:08 EDT 1st July 2015 | BioPortfolio

Matching Channels

Monoclonal Gammopathy of Undetermined Significance MGUS

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Contract Research Organization news

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form o...

Siemens

Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...

Clinical Trials Phase News

Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...

Matching News

Effect of follow-up of MGUS on survival in patients with multiple myeloma

Patients with multiple myeloma (MM) appear to have better survival if they are found to have monoclonal gammopathy of undetermined significance (MGUS) first, the state that precedes MM and which is ty...

MGUS Do Better: Cancer Network & OncoTherapy News

(MedPage Today) -- For cancer patients, time can be irrational.

News Headlines, PTV News: Mar 15, 2010

A look at today's forthcoming news stories including Abbott's latest blockbuster, and news on Roche and Pfizer's failed cancer meds

Prior Knowledge of MGUS Linked to Improved Multiple Myeloma Survival

Multiple myeloma patients had better overall survival if they had prior knowledge of having monoclonal gammopathy of undetermined significance.

PTV News: Nov 26, 2009

Top stories on November 26th, 2009: Unfortunately there is no PharmaTelevision News today as we are relocating our studio. PharmaTelevision News returns tomorrow to bring you the all the latest news o...

News Headlines, PTV News: May 12, 2010

Today's forthcoming news stories: Merck & Co discontinues development of a follow-on biologic; Roche and Galapagos expand "smokers lung" drug R&D collaboration, and Living Cell Technologies discusses ...

News Headlines, PTV News: May 17, 2010

Today's forthcoming news stories: Astellas agrees US $4B acquisition of OSI Pharmaceuticals; GSK is aiming to double revenue from India and China by cutting prices, and Spain becomes the latest EU cou...

Seralite® for multiple myeloma and other B cell dyscrasias

Seralite® is a rapid diagnostic device that has been developed by Abingdon Health for the diagnosis and monitoring of multiple myeloma and other B cell Dyscrasias such as Monoclonal Gammopathy of Und...

Matching PubMed Articles

Characterization of Monoclonal Gammopathy of Undetermined Significance by Calorimetric Analysis of Blood Serum Proteome.

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant proliferative disorder that may progress to multiple myeloma, a malignant plasma cell neoplasia. We evaluated differential s...

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

News in brief.

A roundup of the latest nursing news.

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement